Integrins in the Spotlight of Cancer

Por Bianconi, Daniela, Unseld, Matthias, Prager, Gerald W.
Publicado no Int J Mol Sci (2016)

Angiogenesis in cancer: Anti-VEGF escape mechanisms

Por Prager, Gerald W., Poettler, Marina, Unseld, Matthias, Zielinski, Christoph C.
Publicado no Transl Lung Cancer Res (2012)

CD98hc (SLC3A2) drives integrin-dependent renal cancer cell behavior

Por Poettler, Marina, Unseld, Matthias, Braemswig, Kira, Haitel, Andrea, Zielinski, Christoph C, Prager, Gerald W
Publicado em 2013

Case report: impressive response to pembrolizumab in a patient with mismatch-repair deficient metastasized colorectal cancer and bulky disease

Por Kieler, Markus, Scheithauer, Werner, Zielinski, Christoph C, Chott, Andreas, Al-Mukhtar, Ali, Prager, Gerald W
Publicado no ESMO Open (2016)

Density enhanced phosphatase-1 down-regulates urokinase receptor surface expression in confluent endothelial cells

Por Brunner, Patrick M., Heier, Patricia C., Mihaly-Bison, Judit, Priglinger, Ute, Binder, Bernd R., Prager, Gerald W.
Publicado em 2011

Baseline carcinoembryonic antigen (CEA) serum levels predict bevacizumab-based treatment response in metastatic colorectal cancer

Por Prager, Gerald W, Braemswig, Kira H, Martel, Alexandra, Unseld, Matthias, Heinze, Georg, Brodowicz, Thomas, Scheithauer, Werner, Kornek, Gabriela, Zielinski, Christoph C
Publicado no Cancer Sci (2014)

Nab-paclitaxel as alternative treatment regimen in advanced cholangiocellular carcinoma

Por Unseld, Matthias, Scheithauer, Werner, Weigl, Roman, Kornek, Gabriela, Stranzl, Nadja, Bianconi, Daniela, Brunauer, Georg, Steger, Guenther, Zielinski, Christoph C., Prager, Gerald W.
Publicado no J Gastrointest Oncol (2016)